DANIEL RAMIREZ: Open Payments
NPI 1720097512 · THORNTON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,335 in 38 payments from 10 companies in 2025. Trend: 2023 $163 · 2024 $1,183 · 2025 $1,335
Food & beverage: $1,335
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $752 |
| Novo Nordisk Inc | 8 | $318 |
| Amgen Inc. | 3 | $68 |
| Kowa Pharmaceuticals America, Inc. | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Lilly USA, LLC | 2 | $31 |
| Teva Pharmaceuticals USA, Inc. | 1 | $27 |
| Abbott Laboratories | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| ABBVIE INC. | 1 | $17 |
Products named: AIRSUPRA, BREZTRI, Wegovy, Ozempic, FARXIGA, OTEZLA, ZORYVE, Kerendia.
Industry payments across CO — which companies pay providers there.
